Experimental hyperacute rejection in pancreas allotransplants

Transplantation

Volumn 62, Issue 3, 1996, Pages 324-329

  Hawthorne, Wayne J ^a,b   Griffin, Anthony D ^a   Lau, Howard ^a   Hibbins, Mark ^a   Grierson, Jean M ^a   Ekberg, Henrik ^c   Chapman, Jeremy R ^a   Allen, Richard D M ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; GRAFT SURVIVAL; HISTOPATHOLOGY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; NONHUMAN; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

EID: 0029817473     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199608150-00004     Document Type: Article

References (38)

1. Kissmeyer-Nielsen F, Olsen S, Peterson VP, Fjeldborg O. Hyperacute rejection of kidney allograft, associated with preexisting humoral antibodies against donor cells. Lancet 1966; 2: 662.
2. Williams GM, Lee HM, Weymouth RF, et al. Studies in hyperacute and chronic renal homograft rejection in man. Surgery 1967; 62: 204.
3. Koka P, Cecka JM. Sensitization and crossmatching in renal transplantation. In: Terasaki P (ed). Clinical transplants 1989. Los Angeles: UCLA Tissue Typing Laboratory, 1989: 379.
4. Iwaki Y, Terasaki PI. Primary nonfunction in human cadaver kidney transplantation: evidence for hidden hyperacute rejection. Clin Transplant 1987; 1: 125.
5. Starzl TE, Lerner RA, Dixon FJ, et al. Shwartzman reaction after human renal homotransplantation. N Engl J Med 1968; 278: 642.
6. Williams GM, Hume DM, Hudson RP, Morris PJ, Kano K, Milgrom F. "Hyperacute" renal-homograft rejection in man. N Engl J Med 1968; 279: 611.
7. Vouhe PR, Tamisier D, Le-Bidois J, et al. Pediatric cardiac transplantation for congenital heart defects: surgical considerations and results. Ann Thorac Surg 1993; 56: 1239.
8. Merion RM, Colletti LM. Hyperacute rejection in porcine liver transplantation. 1. Clinical characteristics, histopathology, and disappearance of donor-specific lymphocytotoxic antibody from serum. Transplantation 1990; 49: 861.
9. Bird G, Friend P, Donaldson P, et al. Hyperacute rejection in liver transplantation: a case report. Transplant Proc 1989; 21: 3742.
10. Gordon RD, Iwatsuki S, Esquivel CO, et al. Liver transplant across ABO blood group. Surgery 1986; 100: 342.
11. Gordon RD, Fung JJ, Markus B, et al. The antibody crossmatch in liver transplantation. Surgery 1986; 100: 705.
12. Fung J, Griffin M, Duquesnovy R, et al. Successful sequential liver kidney transplantation in a patient with preformed lymphocytotoxic antibodies. Transplant Proc 1987; 19: 767.
13. Wilson TG, Hawthorne WJ, Greenburg ML, et al. Are kidney and pancreas rejection simultaneous events in combined transplants in dogs? Transplant Proc 1990; 22: 2159.
14. Gruessner RWG, Nakhleh R, Tzardis P, et al. Rejection patterns after simultaneous pancreaticoduodenal-kidney transplants in pigs. Transplantation 1994; 57: 756.
15. Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotoxins. Nature 1964; 204: 998.
16. Deane SA, Ekberg H, Stewart GJ, et al. Canine whole pancreatic transplantation with exocrine drainage into the bladder. Aust NZJ Surg 1989; 59: 659.
17. Zeger S, Liang K. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42: 121.
18. Kux M, Boehmig H, Amemiya H, et al. Modification of hyperacute canine renal homograft and pig-to-dog heterograft rejection by the intra-arterial infusion of citrate. Surgery 1971; 70: 103.
19. Rosenberg JS, Hawkins E, Rector F. Mechanisms of immunological injury during antibody-mediated hyperacute rejection of renal heterografts. Transplantation 1971; 11: 151.
20. Perper RJ, Najarian JS. Experimental renal heterotransplantation. I. In widely divergent species. Transplantation 1966; 4: 377.
21. Rosenberg J, Broersma R, Bullemer G, Mammen E, Lenaghan R, Rosenberg B. Relationship of platelets, blood coagulation, and fibrinolysis to hyperacute rejection of renal xenografts. Transplantation 1969; 8: 152.
22. Kristensen T, Grunnet N, Madsen M, et al. Hyperacute rejection of a kidney allograft may be caused by cytotoxic lymphocytes. Acta Pathol Microbiol Scand 1976; 84: 304.
23. Ahern A, Artruc S, DellaPelle P, et al. Hyperacute rejection of HLA-AB-identical renal allografts associated with B lymphocyte and endothelial reactive antibodies. Transplantation 1982; 33: 103.
24. Simpson KM, Bunch DL, Amemiya H, et al. Humoral antibodies and the coagulation mechanisms in the accelerated or hyperacute rejection of renal homografts in sensitised canine recipients. Surgery 1970; 68: 77.
25. Peltenburg HG, Tiebosch A, Van den Berg-Loonen PM, et al. A positive T cell crossmatch and accelerated acute rejection of a pancreas-spleen allograft. Transplantation 1992; 53: 226.
26. Griffin AD, Hawthorne WJ, AlLen RDM, et al. 24-Hour preservation of canine pancreas allografts using low-cost, low-viscosity, modified University of Wisconsin cold storage solution. Transplant Proc 1993; 25: 1595.
27. Houssin D, Gugenheim J, Bellon B, et al. Absence of hyperacute rejection of liver allografts in hypersensitized rats. Transplant Proc 1985; 17: 293.
28. Knechtle S, Kolbeck PC, Tsuchimoto S, Coundouriotos A, Sanfilippo F, Bollinger RR. Hepatic transplantation into sensitized recipients: demonstration of hyperacute rejection. Transplantation 1987; 43: 8.
29. Gordon RD, Fung JJ, Markus B, et al. The antibody crossmatch in liver transplantation. Surgery 1986; 100: 705.
30. Amery AH, Pegrum GD, Risdon RA, Williams G. Nature of hyperacute (second set) rejection in dog renal allografts and effects of heparin on the rejection process. Br Med J 1973; 1: 455.
31. Ito S, Camussi G, Tetta C, Milgrom F, Andres G. Hyperacute renal allograft rejection in the rabbit: the role of plateletactivating factor and of cationic proteins derived from polymorphonuclear leukocytes and from platelets. Lab Invest 1984; 51: 148.
32. Sandrin MS, Vaughan HA, McKenzie IFC. Identification of Gal(α1,3)Gal as the major epitope for pig-to-human vascularized xenografts. Transplant Rev 1994; 8: 134.
33. MacDonald A, Busch GJ, Alexander JL, Pheteplace, Menzoian J, Murray JE. Heparin and aspirin in the treatment of hyperacute rejection of renal allografts in presensitized dogs. Transplantation 1970; 9: 1.
34. MacDonald AS, Bell WR, Bush GJ, et al. A comparison of hyperacute canine renal allograft and sheep-to-dog xenograft rejection. Transplantation 1972; 13: 146.
35. Henry ML, Han LK, Orosz CG, Sedmak D, Ferguson RM. Modification of xenograft hyperacute rejection via antibody depletion. Transplant Proc 1990; 22: 1081.
36. Leventhal JR, Flores HC, Gruber SA, et al. Evidence that 15-deoxyspergualin inhibits natural antibody production but fails to prevent hyperacute rejection in a discordant xenograft model. Transplantation 1992; 54: 26.
37. Dalmasso AP, Platt JL. Prevention of complement-mediated activation of xenogenic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor. Transplantation 1993; 56: 1171.
38. Mozes MF, Gewurz H, Gunnarson A, et al. Xenograft rejection by dog and man: isolated kidney perfusion with blood and plasma. Transplant Proc 1971; 3: 531.